Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript
Evolent Health Inc EVH
$3.88
▼ -5.37%
($-0.22)
Open
$4.08
Prev Close
$4.10
Day Range
$3.84 – $4.23
52W Range
$2.10 – $12.07
Market Cap
$460.05M
Beta
0.82
EPS (TTM)
$-4.76
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2015-06-05 |
| Shares Out. | 111,640,000 |
| Website | evolent.com/ ↗ |
| Phone | 13026365400 |
Evolent Health Inc is a publicly traded company under the ticker symbol EVH on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
20 analysts (2026-05-01)
📰 Latest News for EVH
Evolent Health, Inc. 2026 Q1 - Results - Earnings Call Presentation
Needham Maintains Buy on Evolent Health, Raises Price Target to $5
Evolent Health Inc - A (NYSE:EVH) Q1 Revenue Miss Overshadowed by EPS Beat
Evolent Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Evolent Health: Q1 Earnings Snapshot
Evolent Health Affirms FY2026 Sales Guidance of $2.400B-$2.600B vs $2.487B Est.
Evolent Health Q1 Adj. EPS $(0.02) Beats $(0.05) Estimate, Sales $496.246M Miss $534.669M Estimate.